Close Menu

Britain's Royal College of Pathologists, as well as other scientific associations, is calling for better regulation of at-home testing kits for disease, including genetic disease. They will be telling members of Parliament that companies offering these tests should deposit the data on the product's efficacy in a database so that their claims can be tested and that an official body should be set up to monitor these products.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.